What is HC Wainwright’s Forecast for Quantum-Si Q1 Earnings?

Quantum-Si incorporated (NASDAQ:QSI) – HC Wainwright lifted their Q1 2025 earnings per share (EPS) estimates for Quantum-Si in a research note issued to investors on Tuesday, March 4th. HC Wainwright analyst S. Ramakanth now forecasts that the company will post earnings of ($0.17) per share for the quarter, up from their previous estimate of ($0.18). HC Wainwright has a “Buy” rating and a $5.50 price objective on the stock. The consensus estimate for Quantum-Si’s current full-year earnings is ($0.65) per share. HC Wainwright also issued estimates for Quantum-Si’s Q2 2025 earnings at ($0.16) EPS, Q3 2025 earnings at ($0.16) EPS, Q4 2025 earnings at ($0.16) EPS, FY2025 earnings at ($0.66) EPS, FY2026 earnings at ($0.60) EPS, FY2027 earnings at ($0.43) EPS and FY2028 earnings at ($0.21) EPS.

QSI has been the subject of a number of other reports. Canaccord Genuity Group reduced their price target on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a report on Wednesday, November 13th. Alliance Global Partners assumed coverage on Quantum-Si in a research note on Friday, February 7th. They issued a “buy” rating and a $3.75 target price for the company.

Quantum-Si Stock Up 1.4 %

NASDAQ:QSI opened at $1.40 on Thursday. Quantum-Si has a twelve month low of $0.61 and a twelve month high of $5.77. The company has a fifty day moving average of $2.24 and a 200-day moving average of $1.45. The firm has a market capitalization of $199.80 million, a P/E ratio of -2.19 and a beta of 2.69.

Insider Buying and Selling at Quantum-Si

In related news, Director Jonathan M. Rothberg sold 3,506,267 shares of the firm’s stock in a transaction dated Friday, December 27th. The shares were sold at an average price of $3.34, for a total value of $11,710,931.78. Following the transaction, the director now owns 1,250,000 shares of the company’s stock, valued at approximately $4,175,000. This trade represents a 73.72 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 30.04% of the stock is currently owned by company insiders.

Institutional Trading of Quantum-Si

Several institutional investors and hedge funds have recently modified their holdings of QSI. XTX Topco Ltd grew its holdings in Quantum-Si by 81.3% during the third quarter. XTX Topco Ltd now owns 43,812 shares of the company’s stock worth $39,000 after buying an additional 19,651 shares in the last quarter. Barclays PLC boosted its holdings in Quantum-Si by 210.5% during the 3rd quarter. Barclays PLC now owns 196,826 shares of the company’s stock worth $173,000 after acquiring an additional 133,438 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Quantum-Si by 6.7% in the 3rd quarter. Geode Capital Management LLC now owns 2,316,921 shares of the company’s stock worth $2,044,000 after acquiring an additional 145,091 shares in the last quarter. SG Americas Securities LLC raised its holdings in shares of Quantum-Si by 12.4% in the fourth quarter. SG Americas Securities LLC now owns 67,588 shares of the company’s stock valued at $182,000 after purchasing an additional 7,470 shares during the last quarter. Finally, Abel Hall LLC bought a new position in shares of Quantum-Si during the fourth quarter valued at about $28,000. 39.90% of the stock is owned by hedge funds and other institutional investors.

Quantum-Si Company Profile

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.